Marksans Pharma Ltd Performance
Open
156.7
Traded Value (Cr)
9.00 Cr
Prev. Close
156.1
VWAP
157.69
Volume
9,03,601
Face Value
1
Marksans Pharma Ltd Fundamentals
Marksans Pharma Ltd Financials
Resistance and Support
₹159.23
PIVOT
 Resistance | |
|---|---|
| First Resistance | ₹163.467 |
| Second Resistance | ₹169.033 |
| Third Resistance | ₹173.267 |
 Support | |
|---|---|
| First Resistance | ₹153.667 |
| Second Resistance | ₹149.433 |
| Third Resistance | ₹143.867 |
| RSI | 33.098 |
| MACD | -1.031 |
| ADX | 34.149 |
| CCI | -128.794 |
Delivery and Volume
About Marksans Pharma Ltd
Marksans Pharma Limited is a public limited company incorporated in the year April 16th, 1982. The Company is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulation. The Company's research and development facilities are located in Verna, Goa and R & D center in Navi Mumbai. The Company on 30th March 2015, issued and allotted 240,06,494 equity shares of Rs1/- each to qualified institutional buyers under QIP for cash at Rs54.67 (including premium) per Equity Share. In accordance to terms of issue, the Directors in their meeting held on 7th February, 2015 decided to redeem entire 13,50,000 7% Redeemable Cumulative Preference Shares of face value Rs100/- per share at par out of profits in tranches before due date of redemption i.e 27th March, 2018. Accordingly, on 7th February 2015, the Directors redeemed 1,00,000 preference shares at par. The Company issued 50,000 Bonds of USD 1,000 each in principal value during the financial year 2015. As on date of report, the Company bought back and extinguished 49,939 Bonds. Of which, only 61 Bonds of USD 1,000 each in principal value (out of total 50,000 Bonds issued) remained outstanding as the same are not traceable During the year 2017, the Company redeemed 1,50,000 preference shares of Rs100/-each at par. Accordingly, issued, subscribed and paid-up preference share capital reduced from 12,50,000 preference shares of Rs100/- each to 11,00,000 preference shares of Rs100/- each with effect from 31st March 2017.
Managing Director
Mark Saldanha
Founded
1992
NSE Symbol
MARKSANS
Marksans Pharma Ltd Management
| Name | Designation |
|---|---|
| Mark Saldanha | Chairman & Managing Director |
| Harshavardhan Panigrahi | Company Sec. & Compli. Officer |
| Seetharama Raju Buddharaju | Non-Exec. & Independent Dir. |
| Sandra Saldanha | Whole-time Director |
| Digant Mahesh Parikh | Non-Exec. & Independent Dir. |
| Varddhman Vikramaditya Jain | Whole-time Director |
| Abhinna Sundar Mohanty | Non-Exec. & Independent Dir. |
| Sunny Sharma | Director |
| Shailaja Vardhan | Independent Director |